Annual Non Current Assets
$12.00 M
-$3.12 M-20.62%
31 December 2023
Summary:
Mersana Therapeutics annual long term assets is currently $12.00 million, with the most recent change of -$3.12 million (-20.62%) on 31 December 2023. During the last 3 years, it has fallen by -$5.21 million (-30.27%). MRSN annual non current assets is now -30.27% below its all-time high of $17.21 million, reached on 31 December 2021.MRSN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$8.97 M
-$1.19 M-11.73%
30 September 2024
Summary:
Mersana Therapeutics quarterly long term assets is currently $8.97 million, with the most recent change of -$1.19 million (-11.73%) on 30 September 2024. Over the past year, it has dropped by -$3.03 million (-25.24%). MRSN quarterly non current assets is now -55.70% below its all-time high of $20.25 million, reached on 30 June 2021.MRSN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -25.2% |
| 3 y3 years | -30.3% | -47.9% |
| 5 y5 years | +93.1% | +44.4% |
MRSN Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.3% | at low | -47.9% | at low |
| 5 y | 5 years | -30.3% | +93.1% | -55.7% | +44.4% |
| alltime | all time | -30.3% | +625.3% | -55.7% | +207.9% |
Mersana Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.97 M(-11.7%) |
| June 2024 | - | $10.16 M(-6.2%) |
| Mar 2024 | - | $10.84 M(-9.7%) |
| Dec 2023 | $214.06 M(-32.9%) | $12.00 M(-8.8%) |
| Sept 2023 | - | $13.17 M(-5.4%) |
| June 2023 | - | $13.91 M(-3.3%) |
| Mar 2023 | - | $14.39 M(-4.8%) |
| Dec 2022 | $319.22 M(+69.0%) | $15.12 M(+2.1%) |
| Sept 2022 | - | $14.81 M(-3.0%) |
| June 2022 | - | $15.27 M(-9.1%) |
| Mar 2022 | - | $16.80 M(-2.4%) |
| Dec 2021 | $188.90 M(-26.9%) | $17.21 M(-5.6%) |
| Sept 2021 | - | $18.23 M(-10.0%) |
| June 2021 | - | $20.25 M(+26.9%) |
| Mar 2021 | - | $15.96 M(+7.7%) |
| Dec 2020 | $258.58 M | $14.82 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $15.19 M(-2.7%) |
| June 2020 | - | $15.61 M(+0.3%) |
| Mar 2020 | - | $15.57 M(+150.5%) |
| Dec 2019 | $101.33 M(+36.4%) | $6.21 M(-10.7%) |
| Sept 2019 | - | $6.96 M(-10.4%) |
| June 2019 | - | $7.77 M(-6.6%) |
| Mar 2019 | - | $8.31 M(+98.1%) |
| Dec 2018 | $74.31 M(-36.8%) | $4.20 M(-3.0%) |
| Sept 2018 | - | $4.33 M(-8.3%) |
| June 2018 | - | $4.72 M(+7.4%) |
| Mar 2018 | - | $4.40 M(-66.6%) |
| Dec 2017 | $117.54 M(+15.0%) | $13.17 M(+112.8%) |
| Sept 2017 | - | $6.19 M(+9.5%) |
| June 2017 | - | $5.66 M(+27.2%) |
| Mar 2017 | - | $4.45 M(+52.6%) |
| Dec 2016 | $102.17 M(+701.1%) | $2.91 M |
| Dec 2015 | $12.75 M | - |
FAQ
- What is Mersana Therapeutics annual long term assets?
- What is the all time high annual non current assets for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly non current assets year-on-year change?
What is Mersana Therapeutics annual long term assets?
The current annual non current assets of MRSN is $12.00 M
What is the all time high annual non current assets for Mersana Therapeutics?
Mersana Therapeutics all-time high annual long term assets is $17.21 M
What is Mersana Therapeutics quarterly long term assets?
The current quarterly non current assets of MRSN is $8.97 M
What is the all time high quarterly non current assets for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly long term assets is $20.25 M
What is Mersana Therapeutics quarterly non current assets year-on-year change?
Over the past year, MRSN quarterly long term assets has changed by -$3.03 M (-25.24%)